First National Bank of South Miami’s Editas Medicine EDIT Stock Holding History

First National Bank of South Miami’s Portfolio EDIT Stock Details EDIT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-1,000	Closed	-$27K	–	344
2021 Q4	$27K	Hold	1,000	–	–	0.02%	259
2021 Q3	$41K	Hold	1,000	–	–	0.03%	226
2021 Q2	$57K	Hold	1,000	–	–	0.04%	206
2021 Q1	$42K	Hold	1,000	–	–	0.03%	204
2020 Q4	$70K	Hold	1,000	–	–	0.06%	167
2020 Q3	$28K	Hold	1,000	–	–	0.03%	193
2020 Q2	$30K	Hold	1,000	–	–	0.03%	183
2020 Q1	$20K	Hold	1,000	–	–	0.03%	201
2019 Q4	$30K	Hold	1,000	–	–	0.03%	187
2019 Q3	$25K	Hold	1,000	–	–	0.02%	209
2019 Q2	$25K	Hold	1,000	–	–	0.02%	212
2019 Q1	$24K	Buy	+1,000	New	+$22.6K	0.02%	215

Other funds holding EDIT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

First National Bank of South Miami's EDIT Position: Q1 2022 in Review

First National Bank of South Miami sold out of Editas Medicine (EDIT) in Q1 2022, closing a stake of 1,000 shares — an estimated $27K sold.

First National Bank of South Miami first reported a position in EDIT in Q1 2019 and held it in 12 quarters. The position peaked at $70K in Q4 2020. 257 funds tracked by Wall St. Rank hold EDIT as of Q1 2022.

First National Bank of South Miami reported no remaining Editas Medicine position as of Q1 2022 after selling out during the quarter.
First National Bank of South Miami sold 1,000 Editas Medicine shares in Q1 2022, an estimated $27K.
First National Bank of South Miami first reported a position in Editas Medicine in Q1 2019 and held it in 12 quarters.
First National Bank of South Miami's Editas Medicine position peaked at $70K in Q4 2020.
257 funds tracked by Wall St. Rank held Editas Medicine as of Q1 2022.

Based on First National Bank of South Miami's 13F filing for Q1 2022, filed 8 Apr 2022.